Contracts › 75N91021F00014
75N91021F00014: Nci-Dcp-21-0103 Coordinating Center for the Nci Cervical Cancer Last Mile Initiative Self-Sampling for Hpv Testing to Improve Cervical Cancer Prevention Ship Trial
Awarded to Leidos Biomedical Research Inc by National Institutes of Health (NIH).
$8.0Mobligated
$8.0Mpotential value
31 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91021F00014 |
|---|---|
| Vehicle | 75N91019D00024 |
| Awardee | Leidos Biomedical Research Inc |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NIH NCI |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | MD |
| Period of performance | 14 September 2021 to 31 December 2026 |
| Potential end | 31 December 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record